08|15|25

Reimagining Omnichannel: A New Blueprint for Pharma Marketing

Dan Gandor, EVP, Head of Omnichannel and Digital Transformation, is leading the conversation on what modern pharma marketing should look like. In a recent article in Pharmaceutical Commerce, he shared his insights on how omnichannel strategy has evolved, from fragmented tactics to orchestrated, customer-first experiences.  Read the blog to learn more.

08|11|25

The Soul of Innovation: Transforming Life Sciences Through Human-Centered Ingenuity

The most effective healthcare marketing doesn’t just inform, it connects. In today’s fast-paced digital world, AI delivers speed and precision, but when paired with human creativity, it becomes a powerful storytelling tool that truly resonates. We’re proud to be featured in Adobe’s blog for using AI to amplify the human experience.

07|25|25

7 Key Cannes Lions Takeaways to Ignite Your Creativity: Webinar Recap

In a recent EVERSANA INTOUCH webinar, Susan Perlbachs, Chief Creative Officer, and John Kenny, Chief Strategy Officer, took us straight to the Croisette with their firsthand takeaways from the 2025 Cannes Lions International Festival of Creativity. The session opened with a powerful reflection that captured today’s marketing challenge:  “When expression is cheap, capturing attention becomes […]

07|10|25

Cannes 2025: How CMOs Define The Future of Work and What’s to Come

Each year, the Cannes Lions International Festival of Creativity brings together the world’s most visionary marketers—and 2025 was no exception. Among the attendees was Angela Tenuta, Global Group President at EVERSANA INTOUCH, who shared her reflections in a recent PharmaLive article after joining peers from around the world to explore the evolving role of marketing leadership.

07|02|25

The Omnichannel Advantage: Insights from Dan Gandor at the DHC Roundtable

Discover how EVERSANA INTOUCH’s Dan Gandor is redefining omnichannel strategy in pharma. Key takeaways from the DHC Roundtable at Amgen reveal scalable innovations from rare disease marketing.

07|01|25

Cannes 2025: Lessons in Branding, AI and the Rise of Creator Content

In his PharmaLive article, John Kenny explores how brands have shifted from speculating about AI to integrating it into creative workflows. From collapsing production timelines to evolving influencer content, discover how AI is reshaping pharma marketing.

06|24|25

Cannes 2025: Pharma’s Creative Inflection Point

In her latest PharmaLive article, Susan Perlbachs, Chief Creative Officer at EVERSANA INTOUCH, reflects on three key themes from this year’s Cannes Lions Festival of Creativity—each signaling a new era for pharmaceutical marketing.

06|16|25

MM+M Top 100 2025: Evolved for Where Pharma’s Going

Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.

06|13|25

AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era

At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]

06|12|25

Inside Google’s AI Mode: Exploring Differentiators to Other AI-Search Options

Google’s AI Mode is fundamentally changing how people find health information online. For pharma marketers, this presents a critical opportunity to build trust and ensure compliance by optimizing content for AI, adapting how we advertise and measuring success. Ensure your brand is prepared. Download the POV to learn more.